A Real-World Study of the Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in HER2- Low Metastatic Breast Cancer (mBC) among Racial and Ethnic Minorities and Older Populations in the United States: Trial in Progress (TiP)

Mackenzie Henderson, Candice Drinkwater, Danielle Potter, Rachel Clark, Divi Alagappan, Shahid Ashfaque, Kellie Ryan, Cecilia Orbegoso Aguilar, Armen A. Ghazarian